Intramedullary and extramedullary B lymphopoiesis in osteopetrotic mice

Blood

Volumn 95, Issue 11, 2000, Pages 3363-3370

  Tagaya, Hisashi ^b   Kunisada, Takahiro ^b   Yamazaki, Hidetoshi ^b   Yamane, Toshiyuki ^b   Tokuhisa, Takeshi ^b   Wagner, Erwin F ^b   Sudo, Tetsuo ^b   Shultz, Leonard D ^b   Hayashi, Shin Ichi ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA; FLT3 LIGAND; INTERLEUKIN 7; RNA; STEEL FACTOR;

ALBERS SCHOENBERG DISEASE; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; COLONY FORMING UNIT; CONTROLLED STUDY; GENE EXPRESSION; HEMATOPOIESIS; LIVER; LYMPHOPOIESIS; MOUSE; MYELOPOIESIS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; SPLEEN;

EID: 0034210949     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.11.3363     Document Type: Article

References (77)

1. Godin I, Dieterlin-Lievre F, Cumano A. Emergence of multipotent hematopoietic cells in the yolk sac and paraaortic splanchnopleura in mouse embryos, beginning at 8.5 days postcoitus. Proc Natl Acad Sci U S A. 1995;92:773-777.
2. Morrison DJ, Uchida N, Weissman IL. The biology of hematopoietic stem cells. Annu Rev Cell Dev. 1995;11:35-71.
3. Dzierzak E, Medvinsky A. Mouse embryonic hematopoiesis. Trends Genet. 1995;11:359-366.
4. Jordan CT, McKearn JP, Lemischka IR. Cellular and developmental properties of fetal hematopoietic stem cells. Cell. 1990;61:953-963.
5. Jacobsen K, Osmond DG. Microenvironmental organization and stromal cell associations of B lymphocyte precursor cells in mouse bone marrow. Eur J Immunol. 1990;20:2395-2404.
6. Mauch P, Rosenblatt M, Hellman S. Permanent loss in stem cell self renewal capacity following stress to the marrow. Blood. 1988;72:1193-1196.
7. Ohno H, Ogawa M, Nishikawa S, et al. Conditions required for myelopoiesis in murine spleen. Immunol Lett. 1993;35:197-204.
8. Wiktor-Jedrzejczak W, Skelly RR, Ahmed A. Hematopoietic stem cell differentiation and its role in osteopetrosis. Immunologic implications. In: Gershwin ME, Marchant B, eds. Immunologic Defects in Laboratory Animals. New York, NY: Plenum Publishing Co; 1981:51-77.
9. Wiktor-Jedrzejczak W, Ahmed A, Szczylik C, Skelly RR. Hematological characterization of congenital osteopetrosis in op/op mouse. J Exp Med. 1982;156:1516-1527.
10. McCarthy DM. Fibrosis of the bone marrow: content and causes. Br J Haematol. 1985;59:1-7.
11. Rossi MID, Dutra HS, El-Cheikh MC. Bonomo A, Borojevic R. Extramedullary B lymphopoiesis in liver schistosomal granulomas: presence of the early stages and inhibition of the full B cell differentiation. Int Immunol. 1999;11:509-518.
12. Haurie C, Dale DC, Mackey MC. Cyclic neutropenia and other periodic hematological disorders: a review of mechanisms and mathematical models. Blood. 1998;92:2629-2640.
13. Russell ES. Hereditary anemias of the mouse: a review for geneticists. Adv Genet. 1979;20:357-458.
14. Kitamura Y. Heterogeneity of mast cells and phenotypic change between subpopulations. Annu Rev Immunol. 1989;7:59-76.
15. Witte ON. Steel locus defines new multipotent growth factor. Cell. 1990;63:5-6.
16. Galli SJ, Zsebo KM, Geissler EN. The kit ligand, stem cell factor. Adv Immunol. 1993;55:1-96.
17. Chabot B, Stephenson DA, Chapman VM, Besmer P, Bernstein A. The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature. 1988;335: 88-89.
18. Geissler EN, Ryan MA, Housman DE. The dominant-white spotting (W) locus ot the mouse encodes the c-kit proto-oncogene. Cell. 1988;55: 185-192.
19. Ogawa M, Matsuzaki Y, Nishikawa S, et al. Expression and function of c-kit in hemopoietic progenitor cells. J Exp Med. 1991;174:63-71.
20. Ogawa M, Nishikawa S, Yoshinaga K, et al. Expression and function of c-Kit in fetal hemopoietic progenitor cells: transition from the early c-Kit-independent to the late c-Kit-dependent wave of hemopoiesis in the murine embryo. Development. 1993;117:1089-1098.
21. Matthews W, Jordan CT, Wiegand GW, Pardoll D, Lemischka IR. A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell. 1991;65:1143-1152.
22. Gratwohl A, Baldomero JH, Roth J, et al. FLT-3 ligand provides hematopoietic protection from total body irradiation in rabbits. Blood. 1988;92: 765-769.
23. Ogawa M, Sugawara S, Kunisada T, et al. Flt3/Flk-2 and c-Kit are not essential for the proliferation of B lymphoid progenitor cells in the bone marrow of the adult mouse. Exp Hematol. 1998; 26:478-488.
24. Mackarehtschian K, Hardin JD, Moore KA, Boast S, Goff SP, Lemischka IR. Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity. 1995;3:147-161.
25. Namen AE, Lupton S, Hjerrild K, et al. Stimulation of B-cell progenitors by cloned murine interleukin-7. Nature. 1988;333:571-573.
26. Kincade PW, Lee G, Pietrangeli CE, Hayashi SI, Gimble JM. Cells and molecules that regulate B lymphopoiesis in bone marrow. Annu Rev Immunol. 1989;7:111-143.
27. Sudo T, Ito M, Ogawa Y, et al. Interleukin-7 production and function in stromal cell-dependent B cell development. J Exp Med. 1989;170:333-338.
28. Sudo T, Nishikawa S, Ohno N, et al. Expression and function of the interleukin-7 receptor in murine lymphocytes. Proc Natl Acad Sci U S A. 1993;90:9125-9129.
29. Peschon JJ, Morrissey PJ, Grabstein KH, et al. Early lymphocyte expansion is severely impaired in interleukin-7 receptor-deficient mice. J Exp Med. 1994;180:1955-1960.
30. von Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SE, Murray R. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med. 1995;181: 1519-1526.
31. Maki K, Sunaga S, Komagata Y, et al. Interleukin-7 receptor-deficient mice lack γδ T cells. Proc Natl Acad Sci U S A. 1996;93:7172-7177.
32. Mertsching E, Grawunder U, Meyer V, Rolink T, Ceredig R. Phenotypic and functional analysis of B lymphopoiesis in interleukin-7-transgenic mice: expansion of pro/pre-B cell number and persistence of B lymphocytes development in lymph nodes and spleen, Eur J Immunol. 1996; 26:28-33.
33. Valenzona HO, Pointer R, Ceredig R, Osmond DG. Prelymphomatous B cell hyperplasia in the bone marrow of interfeukin-7 transgenic mice: precursor B cell dynamics, microenvironmental organization and osteolysis. Exp Hematol. 1996; 24:1521-1529.
34. Yoshida H, Hayashi SI, Kunisada T, et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature. 1990;345:442-444.
35. Wiktor-Jedrzejczak W, Bartocci A, Ferrante AW Jr, et al. Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc Natl Acad Sci U S A. 1990; 87:4828-4832.
36. Hodgkinson CA, Moore KJ, Nakayama A, et al. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell. 1993;74:395-404.
37. Wang ZQ, Ovitt C, Grigoriadis AE, Mohle-Steinlein U, Ruther U, Wagner EF. Bone and haematopoietic defects in mice lacking c-fos. Nature. 1992;360:741-745.
38. Johnson RS, Spiegelman BM, Papaioannou V. Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell. 1992;71:577-586.
39. Hayashi SI, Kunisada T, Ogawa M, et al. Stepwise progression of B lineage differentiation supported by interleukin-7 and other stromal cell molecules. J Exp Med. 1990;171:1683-1695.
40. Lee G, Namen AE, Gillis S, Ellingsworth LR, Kincade PW. Normal B cell precursors responsive to recombinant murine IL-7 and inhibition of IL-7 activity by transforming growth factor-β. J Immunol. 1989;142:3875-3883.
41. Begg SK, Radley JM, Pollard JW, Chisholm OT, Stanley ER, Bertoncello I. Delayed hematopoietic development in osteopetrotic (op/op) mice. J Exp Med. 1993;177:237-242.
42. Niida S, Kaku M, Amano H, et al. Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption. J Exp Med. 1999; 190:293-298.
43. Nilsson SK, Bertoncello I. Age-related changes in extramedullary hematopoiesis in the spleen of normal and perturbed osteopetrotic (op/op) mice [erratum in Exp Hematol. 1994;32:527-528]. Exp Hematol. 1994;22:377-383.
44. Nilsson SK, Bertoncello I. The development and establishment of hemopoiesis in fetal and newborn osteopetrotic (op/op) mice. Dev Biol. 1994; 164:456-462.
45. Wiktor-Jedrzejczak W, Ansari AA, Szperl M, Urbanowska E. Distinct in vivo functions of two macrophage subpopulations as evidenced by studies using macrophage-deficient op/op mouse. Eur J Immunol. 1992;22:1951-1954.
46. Chang MD, Stanley ER, Khalili H, Chisholm O, Pollard JW. Osteopetrotic (op/op) mice deficient in macrophages have the ability to mount a normal T-cell-dependent immune response. Cell Immunol. 1995;162:146-152.
47. Emoto M, Emoto Y, Kaufmann SHE. TCR-mediated target cell lysis by CD4 + NK1 + liver T lymphocytes. Int Immunol. 1997;9:563-571.
48. Kodama HA, Amagai Y, Koyama H, Kasai S. A new preadipose cell line derived from newborn mouse calvaria can promote the proliferation of pluripotent hemopoietic stem cells in vitro. J Cell Physiol. 1982;112:89-95.
49. Okada S, Wang ZQ, Grigoriadis AE, Wagner EF, von Ruden T. Mice lacking c-fos have normal hematopoietic stem cells but exhibit altered B-cell differentiation due to an impaired bone marrow environment. Mol Cell Biol. 1994;14:382-390.
50. Suda T, Udagawa N, Takahashi N. Cells of bone: osteoclast generation. In: Bilezikian JP, Raisz LG, Roden GA, eds. Principles of Bone Biology. New York: Academic Press; 1996:87-102.
51. Hayashi SI, Yamane T, Miyamoto A, et al. Commitment and differentiation of stem cells to the osteoclast lineage. Biochem Cell Biol. 1998;76: 911-922.
52. Roodman GD. Cell biology of the osteoclast. Exp Hematol. 1999;27:1229-1241.
53. Horton JD. Amphibians. In Turner RJ, ed. Immunology: A Comparative Approach. West Sussex, UK: John Wiley & Sons; 1994:69-100.
54. Horton JD, Ratcliffe N. Evolution of immunology. In Roitt I, Brostoff J, Male D, eds. Immunology. 4th ed. London, England: Mosby International; 1996;15.1-15.22.
55. Fawcett DW. The amedullary bones of the Florida manatee. Am J Anat. 1942;71:271-309.
56. Bazzini MD, Reynolds JE III, Essman RA. Erythropoiesis and granulopoiesis in the West Indian manatee, Trichechus manatus (Mammalia: Sirenia). Acta Anat (Basel). 1986;126:150-152.
57. Molineux G, Migdalska A, Szmitkowski M, Zsebo K, Dexter TM. The effects on hematopoiesis of recombinant stem cell factor (ligand for c-kit) administered in vivo to mice either alone or in combination with granutocytes colony-stimulating factor. Blood. 1991;78:961-966.
58. Bodine DM, Seidel NE, Zsebo KM, Orlic D. In vivo administration of stem cell factor to mice increases the absolute number of pluripotent hematopoietic stem cells. Blood. 1993;82:445-455.
59. Wodnar-Filipowicz A, Yancil S, Moser Y, et al. Levels of soluble stem cell factor in serum of patients with aplastic anemia. Blood. 1993;81:3259-3264.
60. Fleming WE, Alpern EJ, Uchida N, Ikuta K, Weissman IL. Steel factor influences the distribution and activity of murine hematopoietic stem cells in vivo. Proc Natl Acad Sci U S A. 1993;90: 3760-3764.
61. Kunisada T, Lu SZ, Yoshida H, et al. Murine cutaneous mastocytosis and epidermal melanocytosis induced by keratinocyte expression of transgenic stem cell factor. J Exp Med. 1998;187: 1565-1573.
62. Whetton AD, Graham GJ. Homing and mobilization in the stem cell niche. Trends Cell Biol. 1999; 9:233-238.
63. Broudy VC, Lin NL, Priestley GV, Nocka K, Wolf NS. Interaction of stem cell factor and its receptor c-kit mediates lodgement and acute expansion of hematopoietic cells in the murine spleen. Blood. 1996;88:75-81.
64. Lai YH, Heslan JM, Poppema S, Elloott JF, Mosmann TR. Continuous administration of IL-13 to mice induces extramedullary hemopoiesis and monocytosis. J Immunol. 1996;156:3166-3173.
65. Hirsch E, Iglesias A, Potocnik AJ, Hartmann U, Fassler R. Impaired migration but not differentiation of haematopoietic stem cells in the absence of β1 integrins. Nature. 1996;380:171-175.
66. Papayannopulou T, Craddock C, Nakamoto B, Priestley GV, Wolf NS. The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen. Proc Natl Acad Sci U S A. 1995;92:9647-9651.
67. Williams DA, Rios M, Stephens C, Patel VP. Fibronectin and VLA-4 in haematopoietic stem cell-microenvironment interactions. Nature. 1991;352: 438-441.
68. Kim CH, Broxmeyer HE. In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: stromal cell-derived factor-1, steel factor, and the bone marrow environment. Blood. 1998;91:100-110.
69. Nagasawa T, Hirota S, Tachibana K, et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature. 1996;382:635-638.
70. Ma Q, Jones D, Springer TA. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity. 1999; 10:463-471.
71. Wang LC, Swat W, Fujiwara Y, et al. The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow. Genes Dev. 1998;12: 2392-2402.
72. Yasuda H, Shima N, Nakagawa N, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and identical to TRANCE/RANKL. Proc Natl Acad Sci U S A. 1998;95:3597-3602.
73. Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998;93: 165-178.
74. Wong BR, Rho J, Arron J, et al. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-jun N-terminal kinase in T cells. J Biol Chem. 1997;272:25, 190-25, 194.
75. Anderson DA, Maraskovsky E, Billingsley WL, et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature. 1997;390:175-179.
76. Kincade PW, Medina KL, Smithson G. Sex hormones as negative regulators of lymphopoiesis. Immunol Rev. 1994;137:119-134.
77. Miyaura C, Onoe Y, Inada M, et al. Increased B-lymphopoiesis by interteukin 7 induces bone loss in mice with intact ovarian function: similarity to estrogen deficiency. Proc Natl Acad Sci U S A. 1997;94:9360-9365.